Apply machine learning to optimize patient recruitment, site selection, and trial design, reducing costs and timelines.
Services

Apply machine learning to optimize patient recruitment, site selection, and trial design, reducing costs and timelines.
Traditional trials waste billions on delays and patient dropout. Our AI services deliver predictive analytics to de-risk your most expensive R&D phase.
Reduce patient recruitment timelines by 40-60% and cut per-patient costs by leveraging predictive analytics instead of manual processes.
We build on federated learning architecture for multi-hospital clinical trials to analyze data across institutions without centralizing sensitive PHI, ensuring privacy and regulatory compliance.
Technical Implementation:
Accelerate your path to market. Explore our related service on AI-Driven Drug Discovery Platform Development for end-to-end R&D acceleration.
Our AI-driven clinical trial optimization services deliver quantifiable improvements across your development pipeline. We focus on specific, measurable outcomes that directly impact your bottom line and accelerate time-to-market.
Leverage predictive analytics to identify and enroll ideal candidates 40-60% faster, reducing costly recruitment delays. Our models analyze historical and real-world data to pinpoint high-probability sites and patient cohorts.
Deploy ML models to predict and monitor site performance, ensuring resources are allocated to high-performing locations. This reduces protocol deviations and improves data quality from day one.
Use early-warning AI systems to identify patients at risk of dropout or non-compliance, enabling proactive intervention. This preserves statistical power and protects trial integrity.
Simulate trial outcomes with AI to optimize study design, sample size, and endpoints before initiation. Implement adaptive trial designs that respond to interim data, shortening timelines.
Unify disparate data sources—EHR, wearables, lab results—into a single AI-powered dashboard for real-time risk monitoring and operational decision-making.
Our solutions are engineered for compliance with FDA, EMA, and ICH GCP guidelines. We provide full model validation, documentation, and transparent audit trails to support regulatory submissions. Learn more about our Bio-AI Regulatory Compliance and Validation services.
A clear, phased approach to deploying AI-driven clinical trial optimization, from initial data assessment to full-scale predictive operations.
| Phase & Key Activities | Timeline | Key Deliverables | Outcome |
|---|---|---|---|
Phase 1: Data Audit & Feasibility | Weeks 1-2 | Data readiness assessment report Initial predictive model feasibility analysis | Clear go/no-go decision with quantified opportunity |
Phase 2: Predictive Model Development | Weeks 3-6 | Custom-trained patient recruitment & site selection models Interactive trial design simulation dashboard | Validated models achieving >85% accuracy in retrospective testing |
Phase 3: Pilot Integration & Validation | Weeks 7-10 | Integrated API endpoints with your CTMS Pilot results report with measured vs. predicted performance | Proof-of-value with measured reduction in screening failure rates |
Phase 4: Full Deployment & Monitoring | Weeks 11-12 | Production-grade AI optimization platform Real-time monitoring dashboard with alerting Comprehensive operational handoff | Operational system driving continuous trial optimization |
Ongoing Support & Model Refinement | Post-deployment | Monthly performance review reports Quarterly model retraining with new data 99.9% uptime SLA for inference services | Sustained 15-30% reduction in patient recruitment timelines |
We build production-grade AI systems that directly address the most costly and time-consuming phases of clinical development. Our solutions are engineered for accuracy, compliance, and seamless integration into existing trial management workflows.
Deploy ML models that analyze electronic health records (EHR) and real-world data to identify and rank eligible patients with >85% precision, accelerating enrollment by 30-50% and reducing costly site over-activation.
Engineer data fusion platforms that evaluate historical site performance, investigator expertise, and regional epidemiology to predict and rank high-performing trial sites, optimizing for patient density and protocol adherence.
Develop simulation engines using reinforcement learning to model thousands of trial design variations (sample size, endpoints, interim analyses), identifying optimal protocols that maximize statistical power while minimizing cost and duration.
Implement continuous monitoring AI that analyzes patient adherence data, site reports, and external factors to predict trial deviations and patient dropouts weeks in advance, enabling proactive mitigation strategies.
Create high-fidelity synthetic control arms using generative AI and causal inference models on historical trial data, reducing the required patient cohort size while maintaining regulatory-grade evidence standards for accelerated approvals.
Build robust, validated, and audit-ready MLOps pipelines ensuring model reproducibility, continuous performance monitoring, and full traceability from data ingestion to inference—critical for FDA 21 CFR Part 11 and GCP compliance.
Explore common questions about our AI-driven clinical trial optimization services, from technical implementation and security to timelines and support.
Contact
Share what you are building, where you need help, and what needs to ship next. We will reply with the right next step.
01
NDA available
We can start under NDA when the work requires it.
02
Direct team access
You speak directly with the team doing the technical work.
03
Clear next step
We reply with a practical recommendation on scope, implementation, or rollout.
30m
working session
Direct
team access